JP
John Pagel
Hematology & Oncology
Credentials: · ·
History
1999–2002- 1996–1999
Internal Medicine
1992–1996
Research
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2016 · 1,585 citations
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · 1,512 citations
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2014 · 1,384 citations
64 papers
38 papers
35 papers
27 papers
23 papers
22 papers
20 papers
- EE
20 papers
